- Home
- COGT vs EE Comparison
COGT vs EE Comparison
Compare COGT & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- EE
- Stock Information
- Founded
- COGT 2014
- EE 2003
- Country
- COGT United States
- EE United States
- Employees
- COGT N/A
- EE N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- EE Oil/Gas Transmission
- Sector
- COGT Health Care
- EE Utilities
- Exchange
- COGT Nasdaq
- EE Nasdaq
- Market Cap
- COGT 1.1B
- EE 914.5M
- IPO Year
- COGT 2018
- EE 2022
- Fundamental
- Price
- COGT $12.07
- EE $23.85
- Analyst Decision
- COGT Strong Buy
- EE Hold
- Analyst Count
- COGT 9
- EE 7
- Target Price
- COGT $20.25
- EE $32.29
- AVG Volume (30 Days)
- COGT 5.0M
- EE 494.8K
- Earning Date
- COGT 08-05-2025
- EE 08-06-2025
- Dividend Yield
- COGT N/A
- EE 0.97%
- EPS Growth
- COGT N/A
- EE 37.63
- EPS
- COGT N/A
- EE 1.53
- Revenue
- COGT N/A
- EE $966,414,000.00
- Revenue This Year
- COGT N/A
- EE $36.94
- Revenue Next Year
- COGT N/A
- EE $18.61
- P/E Ratio
- COGT N/A
- EE $16.18
- Revenue Growth
- COGT N/A
- EE N/A
- 52 Week Low
- COGT $3.72
- EE $17.54
- 52 Week High
- COGT $12.97
- EE $32.99
- Technical
- Relative Strength Index (RSI)
- COGT 78.82
- EE 23.92
- Support Level
- COGT $11.93
- EE $24.53
- Resistance Level
- COGT $12.79
- EE $25.05
- Average True Range (ATR)
- COGT 0.74
- EE 0.79
- MACD
- COGT 0.03
- EE -0.29
- Stochastic Oscillator
- COGT 76.56
- EE 2.67
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.